Human T-cell lymphotropic virus type I (HTLV-I) antibodies in pre-diagnostic serum of patients with familial adult T-cell leukemia/lymphoma (ATL)
β Scribed by Abraham M. Y. Nomura; Eugene T. Yanagihara; William A. Blattner; Gloria Y. F. Ho; Melvin S. Inamasu; Richard K. Severson; Jeffrey M. Nakamura
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Volume
- 8
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
In a study of 7498 American men of Japanese ancestry in Hawaii, 26 incident cases of leukemia or nonβHodgkin's lymphoma were identified after a followβup period of 19 years. Two of the cases, who were brothers, were diagnosed with adult Tβcell leukemia/lymphoma (ATL). Both of these brothers had human Tβcell lymphotropic virus type I (HTLVβI) antibodies in their stored serum which were obtained 4 and 18 years before diagnosis. None of the 24 patients with other hematologic malignancies or the 26 matched controls were HTLVβI antibody positive. This finding lends further support for a role of HTLVβI in the etiology of adult Tβcell leukemia/lymphoma.
π SIMILAR VOLUMES
The serum levels of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) were determined by radioimmunoassay in 38 patients with adult T-cell leukemia (ATL). Levels of serum DHEA and DHEA-S were also measured in 60 human T-lymphotropic virus type I (HTLV-I) carriers, and did not differ from those
Adult T-cell leukernidlymphoma (ATL), a malignancy of mature CDCpositive lymphocytes, has been etiologically linked to the human retrovirus HTLV-I. Although a long latent period is suggested from migrant studies, little prospective information on the risk of developing ATL among persons with HTLV-I